Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Psychoneuroendocrinology. 2013 Jul 26;38(11):10.1016/j.psyneuen.2013.06.032. doi: 10.1016/j.psyneuen.2013.06.032

Table 1.

Descriptive characteristics of study population (n = 935 unless otherwise stated).

Characteristic Mean (standard
deviation) or %
Age (years) 65.3 (9.8)
Sex
 Female (n = 482) 51.6%
 Male (n = 453) 48.4%
Race/ethnicity
 White (n = 183) 19.6%
 Black (n = 258) 27.6%
 Hispanic (n = 494) 52.8%
Education
 ≤High School/GED (n = 449) 48.0%
 Some college to associate
  (n = 264) degree
28.3%
 ≥Bachelors degree (n = 222) 23.6%
Income
 <$5000 (n = 25) 2.64%
 $5000–7999 (n = 48) 5.17%
 $8000–11,999 (n = 72) 7.70%
 $12,000–15,999 (n = 80) 8.58%
 $16,000–19,999 (n = 65) 6.93%
 $20,000–24,999 (n = 79) 8.47%
 $25,000–29,999 (n = 71) 7.59%
 $30,000–34,999 (n = 86) 9.24%
 $35,000–39,999 (n = 56) 6.05%
 $40,000–49,000 (n = 90) 9.68%
 $50,000–74,999 (n = 121) 12.9%
 $75,000–99,999 (n = 60) 6.38%
 ≥$100,000 (n = 82) 8.69%
Body mass index (kg/m2) 29.0 (5.7)
Waist circumference (cm) 100.4 (14.7)
Center for Epidemiological Studies
 Depression (CES-D) Scale score, (n = 933)a 6 (3, 12)
CES-D ≥16, (n = 933) 18.4%
Wake up time (am) 6:39 (1.16)
Smoking status
 Non-current (n = 855) 91.4%
 Current (n = 80) 8.6%
Fasting glucose status
 Normal (n = 576) 61.6%
 Impaired fasting glucose (n = 197) 21.1%
 Diabetes (n = 162) 17.3%
Beta blocker use (n = 144) 15.8%
Hormone replacement therapy use (among women) (n = 505)
 User 8.9%
 Non-user 91.1%
a

Median (interquartile range).